United States · FDA National Drug Code directory
NUPLAZID
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63090-340_2199d74b-37ed-408c-97af-ef036899216b
- Product NDC
- 63090-340
- Form
- CAPSULE
- Composition / generic term
- pimavanserin tartrate
- Labeler
- Acadia Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180628
- Source listing expiry
- 20271231
Source-listed ingredients
- PIMAVANSERIN TARTRATE — 34 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE, PLASTIC (63090-340-30) · 63090-340-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →